Ciprofloxacin And Dexamethasone Suspension/ Drops
Product Images NDC 62756-427

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 62756-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-ciprofoxacin-structure (Spl Ciprofloxacin Structure)

Chemical structure of ciprofloxacin hydrochloride monohydrate, a component of ciprofloxacin and dexamethasone otic suspension.*

FDA Label Image

Spl-dexamethasone-structure (Spl Dexamethasone Structure)

Chemical structure of the active ingredient dexamethasone as shown in the image. The diagram depicts the molecular configuration including functional groups and stereochemistry relevant to dexamethasone.*

FDA Label Image

Spl-fig-a (Spl Figure A)

Illustration showing hands holding a small dropper bottle, likely demonstrating how to properly handle or administer otic suspension or drops.*

FDA Label Image

Spl-fig-b (Spl Figure B)

Black and white line drawing illustration of a person lying on their side with their head supported by a pillow, likely demonstrating a position for administering otic suspension or drops into the ear.*

FDA Label Image

Spl-fig-c (Spl Figure C)

An instructional line drawing illustrating the administration of ear drops. The image shows a hand holding a dropper bottle positioned above an ear canal, with drops being administered into the ear. This likely corresponds to the auricular (otic) administration method for the suspension/drops.*

FDA Label Image

Spl-fig-e (Spl Figure E)

An instructional diagram showing three sequential steps of ear manipulation for administration. The first step shows pulling the outer ear backward, the second step pulling the ear upward, and the third step pulling the ear back again, illustrating proper technique to position the ear for otic suspension or drops administration.*

FDA Label Image

Spl-ifu-fig-a (Spl Ifu Fig A)

An instructional illustration showing hands being washed with running water. The image depicts proper handwashing with visible water flow and hands rubbed together, emphasizing cleanliness.*

FDA Label Image

Spl-label (Spl Label)

Label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension USP, a 7.5 mL topical suspension/drops for ear use. Contains active ingredients ciprofloxacin hydrochloride equivalent to 3 mg base and dexamethasone 1 mg per mL, along with inactive ingredients listed. Distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Medicare Ltd., India. Includes storage instructions and NDC 62756-427-90.*

FDA Label Image

Spl-showbox (Spl Showbox)

Label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension USP, sterile suspension/drops for topical use in the ear. The 7.5 mL product label includes dosage strength, NDC 62756-427-90, manufacturer Sun Pharmaceutical Industries, Inc., and directions to shake well before use. The label features an ear illustration and states Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.